Breaking News Instant updates and real-time market news.

MCRB

Seres Therapeutics

$9.73

0.52 (5.65%)

09:19
08/12/16
08/12
09:19
08/12/16
09:19

Seres Therapeutics recent selloff overdone, says FBR Capital

FBR Capital analyst Vernon Bernardino views the selloff in shares of Seres Therapeutics (MCRB) since July 29 as overdone. After the SER-109 Phase II ECOSPOR clinical study in recurrent Clostridium difficile infection did not achieve its endpoint, the analyst cut his price target for the shares to $23 from $43. He points out, however, that development of the company's other clinical-stage assets are partnered with Nestle (NSRGY). Seres' four other collaborations also represent upside potential in the stock, Bernardino tells investors in a research note. He reiterates an Outperform rating on Seres.

MCRB Seres Therapeutics
$9.73

0.52 (5.65%)

06/06/16
COWN
06/06/16
INITIATION
COWN
Outperform
Seres Therapeutics initiated with an Outperform at Cowen
Cowen analyst Ritu Baral initiated Seres Therapeutics with an Outperform citing high confidence of success in the very near-term Phase II data of lead microbiome candidate SER-109 in prevention of multiply recurrent C. Diff infection. He also sees meaningful value in MCRB's platform and pipeline including Ph2-ready SER-262 for prevention of primary CDI recurrence and Ph1/2 SER-287 in ulcerative colitis.
07/29/16
HCWC
07/29/16
INITIATION
Target $50
HCWC
Buy
Seres Therapeutics assumed with a Buy at H.C. Wainwright
H.C. Wainwright analyst Carol Ann Werther resumed coverage of Seres Therapeutics with a Buy rating and $50 price target.
08/01/16
BOFA
08/01/16
DOWNGRADE
BOFA
Neutral
Seres Therapeutics downgraded to Neutral from Buy at BofA/Merrill
08/01/16
LEER
08/01/16
NO CHANGE
Target $12
LEER
Outperform
Seres Therapeutics price target lowered to $12 from $43 at Leerink
Leerink analyst Joseph Schwartz lowered his price target for Seres Therapeutics to $12 from $43 following the company's "surprisingly disappointing" Phase 2 ECOSPOR data, investigating SER-109 in multiply recurrent Clostridium difficile infection, or rCDI, patients. Further, the analyst says that uncertainty for SER-109 raises negative read-through on other follow-on candidates, such as SER-287 for the treatment of mild-to-moderate Ulcerative Colitis and SER-262 in primary CDI. Leerink has an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

15:00
05/26/17
05/26
15:00
05/26/17
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

NEWM

New Media

$12.75

0.045 (0.35%)

14:51
05/26/17
05/26
14:51
05/26/17
14:51
Conference/Events
New Media management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 01

    Jun

FSIC

FS Investment

$9.25

0.1 (1.09%)

14:48
05/26/17
05/26
14:48
05/26/17
14:48
Hot Stocks
Breaking Hot Stocks news story on FS Investment »

Commonwealth Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONS

Sonus

$6.91

-0.12 (-1.71%)

14:47
05/26/17
05/26
14:47
05/26/17
14:47
Conference/Events
Sonus management to meet with William Blair »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 09

    Jun

GOOG

Alphabet

$969.54

14.58 (1.53%)

, GOOGL

Alphabet Class A

$991.86

14.25 (1.46%)

14:46
05/26/17
05/26
14:46
05/26/17
14:46
Periodicals
Google creates AI-focused venture capital program, Axios reports »

Google has launched a new…

GOOG

Alphabet

$969.54

14.58 (1.53%)

GOOGL

Alphabet Class A

$991.86

14.25 (1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 28

    Jun

  • 19

    Jul

14:45
05/26/17
05/26
14:45
05/26/17
14:45
General news
NY Fed's 4-day reverse repo totaled $169.0 B (55 counterparties) »

NY Fed's 4-day…

OOMA

Ooma

$8.58

0.075 (0.88%)

14:29
05/26/17
05/26
14:29
05/26/17
14:29
Hot Stocks
Ooma CFO acquires 3,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

  • 14

    Jun

SHW

Sherwin-Williams

$334.27

0.18 (0.05%)

, VAL

Valspar

$113.06

0.6 (0.53%)

14:20
05/26/17
05/26
14:20
05/26/17
14:20
Hot Stocks
Sherwin-Williams says Valspar acquisition expected to close on June 1 »

Sherwin-Williams (SHW)…

SHW

Sherwin-Williams

$334.27

0.18 (0.05%)

VAL

Valspar

$113.06

0.6 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$138.26

-0.31 (-0.22%)

, SFTBF

SoftBank

$79.50

3.295 (4.32%)

14:18
05/26/17
05/26
14:18
05/26/17
14:18
Periodicals
SoftBank considering increasing Nvidia stake over time, Bloomberg says »

Bloomberg reported…

NVDA

Nvidia

$138.26

-0.31 (-0.22%)

SFTBF

SoftBank

$79.50

3.295 (4.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jun

$NSD

NASDAQ Market Internals

14:17
05/26/17
05/26
14:17
05/26/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCRX

Ocera Therapeutics

$1.13

-0.01 (-0.88%)

14:17
05/26/17
05/26
14:17
05/26/17
14:17
Conference/Events
Ocera Therapeutics to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

$NYE

NYSE Market Internals

14:16
05/26/17
05/26
14:16
05/26/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAR

Marriott

$106.53

0.65 (0.61%)

14:10
05/26/17
05/26
14:10
05/26/17
14:10
Options
Repeat action in Marriott »

Repeat action in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$479.98

-1.41 (-0.29%)

14:04
05/26/17
05/26
14:04
05/26/17
14:04
Hot Stocks
Chipotle says malware found during investigation of card security incident »

Chipotle Mexican Grill,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$10.87

0.005 (0.05%)

14:04
05/26/17
05/26
14:04
05/26/17
14:04
Conference/Events
Ford to host sales conference call »

Ford U.S. Sales Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

SPY

SPDR S&P 500 ETF Trust

$241.73

-0.03 (-0.01%)

, SPX

S&P 500

14:00
05/26/17
05/26
14:00
05/26/17
14:00
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

The S&P 500 (SPX) is…

SPY

SPDR S&P 500 ETF Trust

$241.73

-0.03 (-0.01%)

SPX

S&P 500

AMZN

Amazon.com

$993.38

13.03 (1.33%)

GOOG

Alphabet

$969.54

14.58 (1.53%)

GOOGL

Alphabet Class A

$991.86

14.25 (1.46%)

FB

Facebook

$151.96

1.92 (1.28%)

MSFT

Microsoft

$69.62

0.85 (1.24%)

AAPL

Apple

$153.87

0.53 (0.35%)

XLI

Industrial Select Sector SPDR

$67.45

0.12 (0.18%)

XLU

Utilities SPDR

$53.38

-0.0232 (-0.04%)

XLY

Consumer Discretionary Sector SPDR

$90.63

0.16 (0.18%)

XLF

Financial Select Sector

$23.66

0.04 (0.17%)

IYR

DJ US Real Estate Index Fund

$79.09

-0.53 (-0.67%)

XLE

Energy Select Sector SPDR

$66.54

0.04 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 01

    Jun

  • 08

    Jun

  • 28

    Jun

  • 19

    Jul

TV

Grupo Televisa

$25.08

0.18 (0.72%)

14:00
05/26/17
05/26
14:00
05/26/17
14:00
Options
Short-term put sellers back in Grupo Televisa »

Short-term put sellers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:00
05/26/17
05/26
14:00
05/26/17
14:00
General news
Energy Action: Baker-Hughes »

Energy Action:…

MNK

Mallinckrodt

$43.29

2.29 (5.59%)

13:59
05/26/17
05/26
13:59
05/26/17
13:59
Hot Stocks
Mallinckrodt denied citizen petition related to Inomax »

The FDA has denied…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

NSANY

Nissan

$19.34

0.06 (0.31%)

, TSLA

Tesla

$316.83

6.61 (2.13%)

13:51
05/26/17
05/26
13:51
05/26/17
13:51
Periodicals
Nissan near deal to sell battery unit for around $1B, Nikkei says »

Nissan Motor (NSANY) is…

NSANY

Nissan

$19.34

0.06 (0.31%)

TSLA

Tesla

$316.83

6.61 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 02

    Oct

PVG

Pretium Resources

$9.24

0.13 (1.43%)

13:50
05/26/17
05/26
13:50
05/26/17
13:50
Options
Call buyers active in Pretrium Resources »

Call buyers active in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
05/26/17
05/26
13:40
05/26/17
13:40
General news
Fedspeak resumes next week with SF Fed dove Williams »

Fedspeak resumes next…

IWM

iShares Trust Russell 2000 Index Fund

$137.74

0.1592 (0.12%)

, RUT

Russell 2000 Index

13:26
05/26/17
05/26
13:26
05/26/17
13:26
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) is…

IWM

iShares Trust Russell 2000 Index Fund

$137.74

0.1592 (0.12%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:17
05/26/17
05/26
13:17
05/26/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
05/26/17
05/26
13:16
05/26/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.